نتایج جستجو برای: refractory nhl lymphoma

تعداد نتایج: 155852  

Journal: :iranian journal of immunology 0
arezou sayad department of medical genetics, shahid beheshti university of medical sciences mohammad taghi akbari department of medical genetics, faculty of medical science, tarbiat modares university mahshid mehdizadeh taleghani bone marrow transplantation center mohammad taheri department of medical genetics, shahid beheshti university of medical sciences abbas hajifathali taleghani bone marrow transplantation center

background: non-hodgkin lymphoma (nhl) includes a wide range of diseases with different clinical and biological features. nhl is usually presented as localized or generalized lymphadenopathy. it has been suggested that the hla class i and ii are associated with susceptibility to nhl. different ethnic groups have been found to have different hla class i and ii alleles which affect nhl. objective...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2003
J Vose V Sneller

Approximately 1.5 million people worldwide are living with various forms of lymphoma, and it is estimated that 300 000 people will die each year. In terms of incidence and mortality, non-Hodgkin’s lymphoma (NHL) is the second fastest growing cancer in the USA and the third fastest growing in the rest of the world. Each year ∼60 000 people in the USA will be diagnosed with NHL. More than half of...

2016
Shankaranand Siddappa Bharatnur Usha Amirtham Chennagiri S Premalata Rekha V Kumar

BackgroundNonHodgkin lymphoma (NHL) is one of the most frequent malignancies in children and adolescents. It represents lymphoid malignancies with diverse clinicopathological and biological features. There are very few studies on the frequency and distribution of NHL in this age group classified according to the WHO classification of 2008. A total of 246 cases with lymphoma were diagnosed in pe...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2001
A Tulpule M U Rarick J Kolitz J Bernstein A Myers L A Buchanan B M Espina A Traynor J Letzer G R Justice D McDonald L Roberts W Boswell B Nathwani A M Levine

PURPOSE To assess the efficacy and toxicity of liposomal daunorubicin administered as a two-hour intravenous infusion to patients with relapsed or refractory non-Hodgkin's lymphoma (NHL). PATIENTS AND METHODS Eligible patients had relapsed or refractory NHL with measurable or evaluable disease, and low grade, select intermediate grade, or mantle cell pathologic types. Prior exposure to an ant...

2014
Shi-Jun Li Hui-Ping Chen Ying-Hua Chen Li-hua Zhang Yuan-Mao Tu Zhi-hong Liu

AIMS To determine the spectrum of renal lesions in patients with kidney involvement in non-Hodgkin's lymphoma (NHL) by renal biopsy. METHODS The clinical features and histological findings at the time of the renal biopsy were assessed for each patient. RESULTS We identified 20 patients with NHL and renal involvement, and the diagnosis of NHL was established following the kidney biopsy in 18...

2014
GUOHUI JIAO ZHONGQING ZHENG KUI JIANG JIE ZHANG BANGMAO WANG

The gastrointestinal tract is the most common location for primary extranodal non-Hodgkin lymphoma (NHL) with cases less commonly found in the intestine. The majority of primary intestinal B-cell lymphomas are exophytic, whereas enteropathy-associated T-cell lymphomas present predominantly as thickened plaques, ulcers or strictures. Crohn's disease (CD) is a chronic inflammatory disease of the ...

Journal: :American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2016
Bryan Do Morgan Mace Amber Rexwinkle

PURPOSE The pharmacology, pharmacokinetics, clinical efficacy, safety and tolerability, dosing and administration, and place in therapy of idelalisib, a targeted therapy for certain types of non-Hodgkin's lymphoma (NHL), are reviewed. SUMMARY Historically, conventional cancer chemotherapy agents were recommended for the management of progressive lymphomas requiring systemic treatment; in rece...

Journal: :Annals of Oncology 2022

Newave Pharmaceutical is developing an investigational compound LP-118, a next generation selective B-cell lymphoma 2 (BCL-2) inhibitor with tuned extra-large (BCL-XL) activity to improve antitumor efficacy and reduce risk for thrombocytopenia. Clinical development of LP-118 includes targeting relapsed or refractory hematological malignancies. BCL-2 BCL-XL are important anti-apoptotic proteins ...

Journal: :Journal of the National Comprehensive Cancer Network : JNCCN 2012
Andrew D Zelenetz Leo I Gordon William G Wierda Jeremy S Abramson Ranjana H Advani C Babis Andreadis Nancy Bartlett John C Byrd Myron S Czuczman Luis E Fayad Richard I Fisher Martha J Glenn Nancy Lee Harris Richard T Hoppe Steven M Horwitz Christopher R Kelsey Youn H Kim Susan Krivacic Ann S LaCasce Auayporn Nademanee Pierluigi Porcu Oliver Press Rachel Rabinovitch Nishitha Reddy Erin Reid Ayman A Saad Lubomir Sokol Lode J Swinnen Christina Tsien Julie M Vose Joachim Yahalom Nadeem Zafar Mary Dwyer Hema Sundar

Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B lymphocytes, T lymphocytes, or natural killer cells. Mantle cell lymphoma (MCL) accounts for approximately 6% of all newly diagnosed NHL cases. Radiation therapy with or without systemic therapy is a reasonable approach for the few patients who present with early-stage disease. Rituximab-ba...

2011
Gaetano Corazzelli Ferdinando Frigeri Manuela Arcamone Luigi Aloj Gaetana Capobianco Cristina Becchimanzi Emanuela Morelli Francesco Volzone Gianpaolo Marcacci Filippo Russo Rosaria De Filippi Secondo Lastoria Antonio Pinto

Patients with recurring T-cell non-Hodgkin lymphoma (T-NHL) are incurable and candidate for investigational agents. Here, we report on five patients with T-NHL refractory to multiple chemotherapy lines, including in all cases alkylators and gemcitabine, who received the third-generation chloroethylnitrosourea fotemustine at a dose of 120 mg/m(2) every 21 d, up to eight courses. Median actual d...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید